Navigation Links
Cadila to Commence Phase I Clinical Trials On ZYH2

Cadila Healthcare Ltd today said it has received approval from Drug Controller General of India (DCGI) to conduct Phase I clinical trials on its New Molecular Entity// (NME) - ZYH2, used for treating diabetes.

In pre-clinical studies on 'ZY H2' displayed that it has the potential to improve insulin resistance and lower blood glucose in diabetic conditions without causing hypoglycemia, the company informed the Bombay Stock Exchange.

It also works favourably to lower the elevated lipid levels and the pre-clinical studies on ZYH2 indicate that this NME may be more effective for diabetics, it added.

The shares of the company closed at Rs 545.50, up 0.06 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Zydus Cadila and Kopran in strategic alliance
2. Cadila gets US FDA approval for Promethazine tablets
3. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
4. Face Transplants To Commence In The UK
5. Pfizer Commences Its Advertising for Celebrex with All the Warnings
6. Natco Pharma Commences Production At Dehradun Unit
7. Chinas First Gay Health Clinic Commences Operations
8. Mental Health - NHS Trust Commences Specialist Transition Service
9. SARS-Free Taiwan to Mark End Phase of Global Fight
10. Spray on contraceptive clears Phase I trial
11. Phase 3 trials of two multi-kinase inhibitors against cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2017)... (PRWEB) , ... September 24, 2017 , ... The Tuscany ... on TripAdvisor and one of Provo's premier boutique resorts, is planning on re-opening the ... the resort after devastating Hurricanes Irma and more recently Hurricane Maria, and the staff ...
(Date:9/24/2017)... ... September 24, 2017 , ... “The Messiah 8 with the ... texts to firsthand experiences. “The Messiah 8 with the 3rd Anti Christ” is the ... I’ve tried to look at all the angles of life,” Velazquez states, “I always ...
(Date:9/24/2017)... ... September 24, 2017 , ... “Star of Bethlehem Study”: is ... Study” is the creation of published author, Duane Engdahl, an investigator who had has ... Faith Publishing, Duane Engdahl’s new book is a thought-provoking essay an event so significant ...
(Date:9/23/2017)... ... September 23, 2017 , ... A September 5 ... Robert Kushner, director of Chicago’s Center for Lifestyle Medicine at Northwestern Medicine. While ... article notes that the center routinely recommends weight loss surgeries for patients who ...
(Date:9/23/2017)... ... ... Can't Win Them All”: the story of an entrepreneur and a family man whose ... lives of young athletes. “You Can't Win Them All” is the creation of ... small town in Northern Ontario, Canada. He is an entrepreneur who manages to ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a leader ... will host an educational session focused on the role ... (CLABSI) prevention at the 2017 Annual Scientific Meeting of ... take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s Prevantics® ...
(Date:9/5/2017)... Sept. 5, 2017  Getinge, a leading global ... vibrant charitable donation program -- "Color for the ... heart defect research by The Children,s Heart Foundation. ... general public are encouraged to download a coloring ... completed artwork to the gallery on the website. ...
(Date:9/1/2017)... WHIPPANY, N.J. , Sept. 1, 2017  Bayer will ... at the European Society for Medical Oncology (ESMO) 2017 Congress, ... studies presented will include new preclinical and clinical data on ... from two earlier pipeline projects. ... of the best minds in cancer research at ESMO," said ...
Breaking Medicine Technology: